BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4792697)

  • 1. Cyclophosphamide in the treatment of adult nephrotic syndrome.
    Gulati PD; Rizvi SN; Ajmani SK; Bhasin RC; Vaishnava H
    J Assoc Physicians India; 1973 Jan; 21(1):23-9. PubMed ID: 4792697
    [No Abstract]   [Full Text] [Related]  

  • 2. Stability of remission in minimal lesion nephrotic syndrome after treatment with prednisolone and cyclophosphamide.
    Dundon S; O'Callaghan U; Raftery J
    Int J Pediatr Nephrol; 1980 Mar; 1(1):22-5. PubMed ID: 7343524
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of cyclophosphamide and corticoids in the treatment of nephrotic syndrome: controlled study].
    Rocha H; Vaccaro Torres CE; Lessa I; Azevêdo Vinhaes L
    Rev Bras Pesqui Med Biol; 1972; 5(1-2):21-8. PubMed ID: 4680451
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term effects of cyclophosphamide therapy in treatment of the "primary" nephrotic syndrome of childhood].
    Lama G
    Pediatria (Napoli); 1976 Jun; 84(2):320-30. PubMed ID: 798171
    [No Abstract]   [Full Text] [Related]  

  • 5. Long term prognosis of the nephrotic syndrome in childhood.
    Schärer K; Minges U
    Clin Nephrol; 1973; 1(3):182-7. PubMed ID: 4783717
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytostatic treatment of nephrotic syndrome in children.
    Miltényi M; Marosvári I; Román H; Visy M; Beregi E; Szepesházi K
    Acta Paediatr Acad Sci Hung; 1970; 11(3):263-76. PubMed ID: 5525401
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of cyclophosphamide treatment of primary nephrotic syndrome in children].
    Starkiewiczowa J; Fydryk J; Lupa B
    Pediatr Pol; 1975 Jan; 50(1):31-6. PubMed ID: 1110844
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA; Levtchenko EN; Wetzels JF
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
    Podracká L; Böör A; Sasinka M
    Cas Lek Cesk; 2008; 147(1):38-43. PubMed ID: 18323041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide in the treatment of glomerulonephritis.
    Ibels LS; Palmer AA; Mahony JF; Stewart JH
    Prog Biochem Pharmacol; 1974; 9():65-81. PubMed ID: 4438383
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide in the treatment of the nephrotic syndrome in childhood.
    Spitzer A
    Pediatrics; 1972 Sep; 50(3):358-60. PubMed ID: 5056408
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult nephrotic syndrome: Clinicopathological correlation and results of treatment.
    Indraprasit S; Boonpucknavig V
    J Med Assoc Thai; 1978 Jan; 61 Suppl 1():46-9. PubMed ID: 627804
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Long-term stability of remission in the nephrotic syndrome after treatment with cyclophosphamide.
    Chantler C; Cameron JS; White RH; Ogg CS
    Arch Dis Child; 1974 Oct; 49(10):823. PubMed ID: 4429383
    [No Abstract]   [Full Text] [Related]  

  • 15. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term cyclophosphamide in corticosteroid treated childhood nephrosis.
    Sheth KJ; Liu CC; Good TA
    Wis Med J; 1974 May; 73(5):S55-60. PubMed ID: 4830366
    [No Abstract]   [Full Text] [Related]  

  • 17. [Verification of indications for kidney biopsy in children with steroid-dependent nephrotic syndrome].
    Idczak-Nowicka E; Ksiazek J; Kryński J; Wyszyńska T
    Pediatr Pol; 1996 Aug; 71(8):679-83. PubMed ID: 8927471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide in minimal-change nephrotic syndrome.
    Uldall PR; Feest TG; Morley AR; Tomlinson BE; Kerr DN
    Lancet; 1972 Sep; 2(7776):537-8. PubMed ID: 4115589
    [No Abstract]   [Full Text] [Related]  

  • 19. Five-year review of nephrotic syndrome in Singapore children.
    Chuan PL; Leng SC; Sinniah R
    J Singapore Paediatr Soc; 1975 Oct; 17(2):113-23. PubMed ID: 1207079
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.
    Cameron JS; Chantler C; Ogg CS; White RH
    Br Med J; 1974 Oct; 4(5935):7-11. PubMed ID: 4425844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.